| Financial Year |
September 30 2020 |
| Monetary Funds |
22,246,500.62 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
1,862,257,429.31 |
| Advances to Suppliers |
2,785,816,538.64 |
| Other Receivables |
49,409,804.31 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,536,339,945.93 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
11,161,661.33 |
| Total Current Assets |
7,267,231,880.14 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
2,218,872,810.50 |
| Investment Properties |
-- |
| Fixed Assetes |
3,333,953,802.93 |
| Under-construction Projects |
252,936,933.12 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
866,057,187.05 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
6,578,647.02 |
| Deferred Income Tax Assets |
427,170,030.41 |
| Other Non-Current Assets |
553,928,501.82 |
| Sub-Total of Non-Current Assets |
8,027,180,112.85 |
| Total Assets |
15,294,411,992.99 |
| Short-Term Loans |
3,674,643,670.94 |
| Trading Financial liabilities |
-- |
| Notes Payable |
147,268,971.48 |
| Accounts Payable |
493,712,493.81 |
| Accounts Received In Advance |
98,636,244.13 |
| Employee Compensation Payable |
17,922,986.21 |
| Taxes Payable |
564,187,795.45 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
394,953,794.92 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,040,070,025.43 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
7,431,395,982.37 |
| Long-term Loans |
615,080,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
31,289,072.66 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
725,963,163.60 |
| Total Liabilities |
8,157,359,145.97 |
| Paid-In Capital(Or Share Stock) |
1,482,870,004.00 |
| Capital Surplus |
2,459,229,285.77 |
| Surplus Reserve |
551,412,020.52 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,944,388,591.03 |
| Minority Stockholder's Interest |
-7,781,678.61 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
7,144,834,525.63 |
| Owner's Equity（Stockholder's Equity） |
7,137,052,847.02 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
15,294,411,992.99 |
